Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women
Open Access
- 16 June 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 9 (12), e015997
- https://doi.org/10.1161/jaha.119.015997
Abstract
Background Approximately 60% of women have Stage B heart failure 1 year after a preeclamptic delivery. Emerging evidence suggests that the profibrotic growth factor activin A, which has been shown to induce cardiac fibrosis and hypertrophy, is elevated in preeclampsia and may be inhibited by aspirin therapy. We hypothesized that preeclamptic women receiving aspirin would have lower activin A levels and reduced global longitudinal strain (GLS), a sensitive measure of cardiac dysfunction, than women who do not receive aspirin. To test our hypothesis, we performed a cohort study of women with preeclampsia or superimposed preeclampsia and compared activin A levels and GLS in parturients who did or did not receive aspirin. Methods and Results Ninety‐two parturients were enrolled, of whom 25 (27%) received aspirin (81 mg/day) therapy. GLS, plasma activin A, and follistatin, which inactivates activin A, were measured. Women receiving aspirin therapy had lower median (interquartile range) levels of activin A (8.17 [3.70, 10.36] versus 12.77 [8.37, 31.25] ng/mL; P=0.001) and lower activin/follistatin ratio (0.59 [0.31, 0.93] versus 1.01 [0.64, 2.60] P=0.002) than women who did not receive aspirin, which also remained significant after multivariable analysis. Furthermore, GLS was worse in patients who did not receive aspirin (−19.84±2.50 versus −17.77±2.60%; P=0.03) despite no differences in blood pressure between groups. Conclusions Our study suggests that antepartum aspirin therapy reduced serum activin A levels and improved GLS in preeclamptic patients, suggesting that aspirin may mitigate the postpartum cardiac dysfunction seen in women with preeclampsia.Keywords
This publication has 30 references indexed in Scilit:
- Pre-eclampsia and Cardiovascular Disease Risk Assessment in WomenAmerican Journal of Perinatology, 2016
- Detection of Myocardial Dysfunction in Septic ShockAnesthesia & Analgesia, 2015
- Fully Automated Versus Standard Tracking of Left Ventricular Ejection Fraction and Longitudinal StrainJournal of the American College of Cardiology, 2015
- The activins and their binding protein, follistatin—Diagnostic and therapeutic targets in inflammatory disease and fibrosisCytokine & Growth Factor Reviews, 2013
- Subclinical Left Ventricular Dysfunction in Preeclamptic Women With Preserved Left Ventricular Ejection FractionCirculation: Cardiovascular Imaging, 2012
- Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected PreeclampsiaCirculation, 2012
- Critical illness outcome study: an observational study of protocols and mortality in intensive care unitsOpen Access Journal of Clinical Trials, 2011
- Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsiaCell and tissue research, 2011
- Maternal Circulating Levels of Activin A, Inhibin A, sFlt-1 and Endoglin at Parturition in Normal Pregnancy and Pre-EclampsiaPLOS ONE, 2009
- Maternal serum activin A levels in association with intrauterine fetal growth restrictionBJOG: An International Journal of Obstetrics and Gynaecology, 2003